Dave Singh

Statistics

Publications

Citations

149

H-Index

Active since

2010

Affiliations

Manchester University NHS Foundation Trust(Current)

University of Alabama at Birmingham

Medicines Evaluation Unit

Dave Singh is an author at Manchester University NHS Foundation Trust specializing in chronic obstructive pulmonary disease, respiratory disease, and pulmonology.

Publications per year

2010–2025

Publications

Identification of Lipocalin and Apolipoprotein A1 as Biomarkers of Chronic Obstructive Pulmonary Disease

Paul Skipp, Sheila J. Barton, Dave Singh et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 75 citations

Life Sciences, Biochemistry, Molecular Biology +17

The EvA study: aims and strategy

Loems Ziegler‐Heitbrock, Marion Frankenberger, Irene Heimbeck et al. · European Respiratory Journal · 2012 · 27 citations · Full text

Medicine, Clinical Sciences, Molecular Medicine +17

Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial

Stephanie A. Christenson, Nicola A. Hanania, Surya P. Bhatt et al. · The Lancet Respiratory Medicine · 2025 · 21 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Increased fibrinaloid microclot counts in platelet-poor plasma are associated with Long COVID

Caroline Dalton, Madalena Oliveira, Prachi Stafford et al. · medRxiv · 2024 · 15 citations · Full text

Medicine, Infectious Diseases, Pathology +17

ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD

R. Chad Wade, Fernando J. Martinez, Gerard J. Criner et al. · European Respiratory Journal · 2024 · 11 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

1–5 of 5